Study of Tranexamic Acid Given by Injection to Prevent Heavy Bleeding After Childbirth in Women at Increased Risk
Led by London School of Hygiene and Tropical Medicine · Updated on 2026-11-04
40000
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether tranexamic acid TXA given just before childbirth can prevent postpartum haemorrhage PPH, a leading cause of maternal deaths worldwide. This Phase 3 trial focuses on women at higher risk of PPH, comparing different methods of administering TXA to assess its effects on preventing heavy bleeding and evaluating potential side effects and important maternal health outcomes.
Participants will be randomly assigned to one of three groups receiving TXA as intramuscular injections plus a placebo intravenous injection, TXA by intravenous injection plus placebo intramuscular injections, or placebo by both routes. The study compares the effects of intramuscular and intravenous TXA administered around the time of delivery to determine which method may best prevent PPH.
During the trial, participants will be closely monitored for blood loss up to 24 hours after birth, vital signs, and any bleeding-related complications or side effects. Researchers will also assess blood tests, surgical outcomes for cesarean births, maternal adverse events, and neonatal health up to 42 days postpartum. The study aims to provide detailed safety and effectiveness data while participants receive standard hospital care, with total participation lasting through hospital discharge or up to 42 days after birth.
CONDITIONS
Brief Title
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women at Higher Risk
Research Team
J
Judith Lieber
I
Ian Roberts
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Admitted to hospital to give birth vaginally or by caesarean section
Have one or more known risk factors for postpartum haemorrhage
You will not qualify if you...
Women with a clear medical indication or contraindication for tranexamic acid
Women with ongoing bleeding before childbirth (antepartum haemorrhage)
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 24 hours after birth
Participants receive tranexamic acid or placebo injections by intramuscular or intravenous routes around the time of childbirth.
Continuous monitoring during hospital stay
Follow-up
Duration - Up to 42 days after birth
Participants are monitored for health outcomes, side effects, and neonatal status up to 42 days postpartum or until hospital discharge.
Regular assessments during hospital stay and follow-up contacts
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Similar Trials
Evaluating Intravenous Calcium Gluconate to Reduce Blood Loss After Vaginal Delivery
Evaluating Carbetocin Alone Versus Carbetocin Plus Oxytocin Infusion for Blood Loss Prevention in Elective Cesarean Delivery A Randomized, Double-Blind Controlled Study
Study of Carbetocin Compared to Oxytocin to Prevent Heavy Bleeding After Twin Births
Study to Compare Effects of Uterotonic Drugs After Carbetocin Dose
on Uterine Muscle Using Tissue Samples from Cesarean Section
A Study Comparing Two Medications Misoprostol and Oxytocin Versus One Medication Oxytocin Only to Prevent Early Postpartum Bleeding in Women
Study of How Ephedrine, Phenylephrine, and Norepinephrine Affect Uterine Muscle Contraction in Pregnant Women With Type II and Gestational Diabetes During Cesarean Delivery
Evaluating Simulation-Based Training for Postpartum Hemorrhage Management
in Senior Anesthesiology Residents to Improve Team Performance and Crisis Skills
Long-Term Outcomes of Vacuum-Induced Tamponade for Postpartum Hemorrhage
Observational Study at a Single Tertiary Center
Non-invasive Zinc Protoporphyrin Measurement to Detect Iron Deficiency During and After Pregnancy
Observational Study on Impact of Iron Deficiency on Maternal Health and Postpartum Outcomes
Randomized Trial of the Jada4 System Compared to Standard Care for Treating Postpartum Hemorrhage in Women Aged 18 to 44
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I'M WOMAN).